Skip to main content

Animations

MJFF Publications

8021 - 8030 of 8620 Results
Title
Year
  • Year
  • 2024
  • 2021
  • 2022
  • 2025
  • 2019
  • 2023
  • 2020
  • 2018
  • 2016
  • 2022
  • Summary Details
    OPEN
    Title: Alterations of PINK1-PRKN signaling in mice during normal aging
    Journal Name: Autophagy Reports
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1080/27694127.2024.2434379
    Citation Count: 3
  • Summary Details
    OPEN
    Title: α‐Synuclein in Plasma‐Derived Extracellular Vesicles Is a Potential Biomarker of Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28639
    Citation Count: 77
  • Summary Details
    OPEN
    Title: Aromaticity at position 39 in α‐synuclein: A modulator of amyloid fibril assembly and membrane‐bound conformations
    Journal Name: Protein Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/pro.4360
    Citation Count: 9
  • Summary Details
    RESTRICTED
    Title: Novel Non-Invasive PET Imaging of Reactive Oxygen Species Using [18 F]ROStrace in Three Proteinopathy-Associated Neurodegenerative Mouse Models.
    Journal Name: Academic Radiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1016/j.acra.2025.07.061
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Genetic, Structural, and Functional Evidence Link TMEM175 to Synucleinopathies
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/ana.25629
    Citation Count: 93
  • Summary Details
    OPEN
    Title: Characterizing expression changes in noncoding RNAs during aging and heterochronic parabiosis across mouse tissues
    Journal Name: Nature Biotechnology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41587-023-01751-6
    Citation Count: 34
  • Summary Details
    RESTRICTED
    Title: Dopamine-mediated improvements in dynamic balance control in Parkinson’s disease
    Journal Name: Gait & Posture
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.gaitpost.2020.08.132
    Best OA location URL:
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Destabilizing Domains Enable Long-Term and Inert Regulation of GDNF Expression in the Brain
    Journal Name: Molecular Therapy - Methods & Clinical Development
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.omtm.2018.08.008
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Development and Antiparkinsonian Activity of VU0418506, a Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor 4 Homomers without Activity at mGlu2/4 Heteromers
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acschemneuro.6b00036
    Citation Count: 57
  • Summary Details
    OPEN
    Title: Progression of regional cortical cholinergic denervation in Parkinson’s disease
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/braincomms/fcac320
    Citation Count: 25
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.